NRIX - Financial Reports List - Nurix Therapeutics, Inc. - IntrinsicAlpha

Nurix Therapeutics, Inc. NRIX

Healthcare - Biotechnology - NASDAQ - US

$ 11.46

3.03 %

$ 874 M

Market Cap

-3.78

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-02-28	11.26%	-35.73%	-39.02%
Quarterly Report	Q4	8-K	2024-11-30	-12.37%	-39.55%	-42.62%
Annual Report	FY	10-K	2024-11-30	-29.15%	-34.47%	-37.38%
Quarterly Report	Q3	8-K	2024-08-31	-31.84%	-32.38%	-36.49%
Quarterly Report	Q2	8-K	2024-05-31	-60.58%	-104.44%	-81.36%
Quarterly Report	Q1	8-K	2024-02-29	30.74%	-17.50%	-5.28%
Quarterly Report	Q4	8-K	2023-11-30	123.49%	-0.60%	6.89%
Annual Report	FY	10-K	2023-11-30	99.31%	13.31%	15.67%
Quarterly Report	Q3	8-K	2023-08-31	71.13%	17.27%	14.35%
Quarterly Report	Q2	8-K	2023-05-31	168.33%	51.67%	41.45%

1